AZN icon

AstraZeneca

1,369 hedge funds and large institutions have $45.1B invested in AstraZeneca in 2025 Q4 according to their latest regulatory filings, with 242 funds opening new positions, 490 increasing their positions, 411 reducing their positions, and 119 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
1,369
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
21
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$591M
Puts
$420M
Net Calls
Net Calls Change

Top Buyers

1 +$420M
2 +$412M
3 +$327M
4
Citigroup
Citigroup
New York
+$204M
5
Barclays
Barclays
United Kingdom
+$180M

Top Sellers

1 -$924M
2 -$831M
3 -$550M
4
Primecap Management
Primecap Management
California
-$258M
5
Citadel Advisors
Citadel Advisors
Florida
-$241M
Name Holding Trade Value Shares
Change
Change in
Stake
EF
1401
Empowered Funds
Pennsylvania
LFAS
1402
Level Four Advisory Services
Texas
BCA
1403
Bay Colony Advisors
Massachusetts
EGM
1404
Engineers Gate Manager
New York
LIP
1405
Lighthouse Investment Partners
Florida
Optiver Holding
1406
Optiver Holding
Netherlands
GIC
1407
Generali Investments CEE
Czech Republic
NSEDCP
1408
NJ State Employees Deferred Compensation Plan
New Jersey
P
1409
Pitcairn
Pennsylvania
BHCM
1410
Brevan Howard Capital Management
Jersey
CLGM
1411
Capitolis Liquid Global Markets
New York
LFA
1412
Legacy Financial Advisors
Kentucky
SMH
1413
Sanders Morris Harris
Texas
MIP
1414
Marietta Investment Partners
Wisconsin
SN
1415
Sittner & Nelson
Oregon
BFM
1416
Boothbay Fund Management
New York
WWM
1417
Whalen Wealth Management
Nevada
RCA
1418
Riverview Capital Advisers
Massachusetts
HSA
1419
HBK Sorce Advisory
Pennsylvania
OAC
1420
OMERS Administration Corp
Ontario, Canada
CT
1421
Coastline Trust
Rhode Island
HCM
1422
Howland Capital Management
Massachusetts
BFS
1423
Bradley Foster & Sargent
Connecticut
PP
1424
Prospector Partners
Connecticut
BJL
1425
Brighton Jones LLC
Washington